Metastases to lung and Skin exfoliation

Summary:

Skin exfoliation is found among people with Metastases to lung, especially for people who are male, 60+ old.

The study analyzes which people have Skin exfoliation with Metastases to lung. It is created by eHealthMe based on reports of 107 people who have Metastases to lung from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Metastases to lung?

Metastases to lung (cancer spreads to lung) is found to be associated with 835 drugs and 849 conditions by eHealthMe. Check the latest studies of Metastases to lung.

What is Skin exfoliation?

Skin exfoliation (removal of the oldest dead skin cells) is found to be associated with 1,733 drugs and 1,993 conditions by eHealthMe. Check the latest studies of Skin exfoliation.

On Jul, 24, 2026

107 people who have Metastases To Lung and Skin Exfoliation are studied.

Would you have Skin exfoliation when you have Metastases to lung?

Gender of people who have Metastases to lung and experienced Skin exfoliation *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Skin exfoliation?

- Check whether Skin exfoliation is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Metastases to lung (19,400 reports)
Skin exfoliation (79,571 reports)

All the drugs that are associated with Skin exfoliation:

Skin exfoliation (1,733 drugs)

All the conditions that are associated with Skin exfoliation:

Skin exfoliation (1,993 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Skin exfoliation and Metastases to lung, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.